Simultaneous Inhibition of Histone Deacetylases and RNA Synthesis Enables Totipotency Reprogramming in Pig SCNT Embryos

Author:

de Macedo Mariana PriottoORCID,Glanzner Werner GiehlORCID,Gutierrez KarinaORCID,Currin Luke,Guay Vanessa,Carrillo Herrera Maria Elena,da Silva ZigomarORCID,Baldassarre HernanORCID,McGraw SergeORCID,Bordignon VilceuORCID

Abstract

Combining somatic cell nuclear transfer (SCNT) with genome editing technologies has emerged as a powerful platform for the creation of unique swine lineages for agricultural and biomedical applications. However, successful application of this research platform is still hampered by the low efficiency of these technologies, particularly in attaining complete cell reprogramming for the production of cloned pigs. Treating SCNT embryos with histone deacetylase inhibitors (HDACis), such as Scriptaid, has been routinely used to facilitate chromatin reprogramming after nuclear transfer. While increasing histone acetylation leads to a more relaxed chromatin configuration that facilitates the access of reprogramming factors and DNA repair machinery, it may also promote the expression of genes that are unnecessary or detrimental for normal embryo development. In this study, we evaluated the impact of inhibiting both histone deacetylases and RNA synthesis on pre- and post-implantation development of pig SCNT embryos. Our findings revealed that transcription can be inhibited for up to 40 h of development in porcine embryos, produced either by activation, fertilization or SCNT, without detrimentally affecting their capacity to form a blastocyst and their average number of cells at this developmental stage. Importantly, inhibiting RNA synthesis during HDACi treatment resulted in SCNT blastocysts with a greater number of cells and more abundant transcripts for genes related to embryo genome activation on days 2, 3 and 4 of development, compared to SCNT embryos that were treated with HDACi only. In addition, concomitant inhibition of histone deacetylases and RNA synthesis promoted the full reprograming of somatic cells, as evidenced by the normal fetal and full-term development of SCNT embryos. This combined treatment may improve the efficiency of the genome-editing + SCNT platform in swine, which should be further tested by transferring more SCNT embryos and evaluating the health and growth performance of the cloned pigs.

Funder

Natural Sciences and Engineering Research Council

The Fonds de Recherche du Quebéc—Nature et technologie

The NSERC Collaborative Research and Training (CREATE) program—Genome Editing for Food Security and Environmental Sustainability

The Brazilian Coordination for the Improvement of Higher Education Personnel

The Fonds de Recherche du Québec—Santé (FRQS) Junior 2 salary award

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Reference56 articles.

1. Efficacy of the porcine species in biomedical research;Front Genet,2015

2. Viable offspring derived from fetal and adult mammalian cells;Nature,1997

3. Chromatin role in early programming of embryos;Anim. Front.,2021

4. Derivation of induced pluripotent stem cells from pig somatic cells;Proc. Natl. Acad. Sci. USA,2009

5. Establishment of porcine and human expanded potential stem cells;Nat. Cell Biol.,2019

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Histone Acetyltransferase and Deacetylase Inhibitors—New Aspects and Developments;International Journal of Molecular Sciences;2023-11-30

2. Somatic Cell Nuclear Transfer in Pigs;Methods in Molecular Biology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3